Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
14 Cards in this Set
- Front
- Back
Insulinogouges
|
Osu
Repaglinide Exenatide Sitagliptin |
|
OSU MoA:
|
K+ channel blocker= Membrane depolarization= calcium influx= insulin release
INCREASES INSULIN RECEPTOR SENSITIVITY |
|
Acetohexamide Usage
|
Decrease dose in renal dysfunction
|
|
Glipizide
|
Decrease dose in hepatic dysfunction
|
|
Glyburide
|
Decrease dose in renal dysfunction
|
|
OSU SE:
|
Early morning hypoglycemia( 2-3 AM)
Weight gain Drug Interaction-Increased Hypoglycemia with cimetidine, insulin, salicylates and sulphonamides-All protein bound |
|
Metformin MoA
|
Increased tissue sensitivity to insulin and decreased hepatic gluconeogenesis
synergistic with OSU's |
|
Miglitol
Acarbose MoA and SE |
Inhibits a-glucosidase in brush borders of small intestine=decreased glucose absorption
|
|
Miglitol
Acarbose SE |
No hypoglycemia, Heptatotoxicity, flatulence. diarrhea
|
|
Pioglitazone and Rosiglitazone MoA and SE
|
Activates peroxisome proliferator- activating receptors, increases insulin sensitivity and decreases hepatic gluconeogenesis
|
|
Exenatide MoA
|
GLP-1 Receptor agonist(insulinogogue)
|
|
Sitagliptin MoA
|
Inhibits dipeptidyl peptidase-4 thereby inhibiting inactivation of GLP-1( Insulinogogue)
|
|
Pramlintide MoA
|
Synthetic version of amylin slows down the rate at which food is absorbed from the intestine, decreses apetite
Used in DM T1 and T2 |
|
Minoxidil and Diazoxite MoA
|
Open ATP dependent K+ Channels MoA opposite of OSU's
Decreases insulin release |